Maquet beats Boston and St Jude to US LAA market
This article was originally published in Clinica
Executive Summary
Maquet Cardiovascular has gained a foothold in the left atrial appendage (LAA) closure market, viewed by key heart device makers as a growth area, with the acquisition of LAAx.